Timeline
Armelle Phalipon
Group Leader
07 Oct 2022
27 Apr 2022
publication
The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella.
Read more17 Mar 2022
25 Aug 2018
25 Aug 2018
patent
Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri (SF6)
Read more25 Aug 2018
patent
Glycoconjugates and use thereof as vaccines against Shigella flexneri serotype 3a and X
Read more25 Aug 2018
patent
Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri
Read more25 Sep 2017
24 Apr 2017
03 Jun 2016
27 Mar 2016
27 Mar 2016
08 Oct 2015
project
GPF Vaccinology Call 1: Open call for new ideas for cutting-edge science investigations in vaccinology.
Read more08 Oct 2015
project
GPF Vaccinology Call 2: Accelerating Preclinical Development of Vaccine Candidates
Read more07 Oct 2015
26 Sep 2015
12 Sep 2015
04 Jun 2015
01 Mar 2015
09 Feb 2015
28 Jun 2014
publication
Non-stoichiometric O-acetylation of Shigella flexneri 2a O-specific polysaccharide: synthesis and antigenicity
Read more02 Jun 2014
06 Mar 2014
24 May 2011
publication
Dynamic aspects of antibody:oligosaccharide complexes characterized by molecular dynamics simulations and saturation transfer difference nuclear magnetic resonance
Read more21 Apr 2011
publication
The Shigella flexneri type three secretion system effector IpgD inhibits T cell migration by manipulating host phosphoinositide metabolism.
Read more01 Jan 2011
28 Oct 2010
publication
Effects of backbone substitutions on the conformational behavior of Shigella flexneri O-antigens: implications for vaccine strategy
Read more20 Jan 2010
publication
Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity
Read more27 Mar 2009
publication
Structural mimicry of O-antigen by a peptide revealed in a complex with an antibody raised against Shigella flexneri serotype 2a
Read more15 Feb 2009
publication
A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection
Read more10 Jul 2008
publication
Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path?
Read more18 Apr 2007
09 Jan 2007
publication
Shigella’s ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?
Read more26 Oct 2005
publication
Toward a better understanding of the basis of the molecular mimicry of polysaccharide antigens by peptides: the example of Shigella flexneri 5a
Read more20 Feb 2004
publication
Blockwise approach to fragments of the O-specific polysaccharide of Shigella flexneri serotype 2a: convergent Synthesis of a decasaccharide representative of a dimer of the branched repeating unit
Read more18 Aug 2003
publication
Conformational studies of the O-specific polysaccharide of Shigella flexneri 5a and of four related synthetic pentasaccharide fragments using NMR and molecular modeling
Read more01 Jun 2003
publication
Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells
Read more01 Feb 2003
publication
Novel functions of the polymeric Ig receptor: well beyond transport of immunoglobulins
Read more01 Jan 2003
publication